EUVIMEDOpdag EUVIMED
Crossref

Pomegranate polyphenol punicalagin improves learning memory deficits, redox homeostasis, and neuroinflammation in aging mice

Peng Chen iD, Fuchao Chen, Jiexin Lei, Benhong Zhou iD

Phytotherapy Research · 2023-09 · 37 (9) · 3655-3674

DOI: 10.1002/ptr.7848 ↗

At a glance

Journal article in Phytotherapy Research, published online on 2023-04-24. Written by Peng Chen and 3 co-authors. Institution: Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China. Major MEDLINE topics: Pomegranate, Alzheimer Disease. Cited 40 times so far (Crossref); 49 references. Funded by: Hubei Provincial Natural Science Foundation of China.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Alzheimer's disease (AD) is an irreversible, progressive brain disorder characterized by loss of memory and cognitive dysfunction in the aged. Despite remarkable advances in drug therapy, effective pharmacological interventions are rare. Punicalagin (PU) is an active antioxidant polyphenol found in pomegranates, raspberries, blueberries, and chestnuts that has attracted considerable attention owing to its strong antioxidant and anti‐inflammatory properties. The current study focused on the neuroprotective effect of PU on aging mice and its potential mechanisms. In this study, we first evaluated the protective effect of PU on neuro‐2a (N2a) cell damage mediated by BV2 microglia‐induced neuroinflammation. The in vivo D‐galactose (D‐gal)‐induced brain aging model demonstrated that PU ameliorated deficits in learning and memory and prevented neuroinflammation, which was evident from the decrease in microglial activation and astrocytosis. Furthermore, PU reduced the levels of malondialdehyde (MDA) and reactive oxygen species (ROS) and inhibited NLRP3 inflammasome activation, reducing the levels of inflammatory cytokines, such as interleukin‐6 (IL‐6), tumor necrosis factor‐a (TNF‐a), interleukin‐18 (IL‐18), and interleukin‐1 beta (IL‐1β) in both accelerated aging and naturally senescent mouse models. PU effectively improved neuroinflammation, learning and memory deficits, and redox homeostasis in aging mice, and it could be a potential therapeutic agent for AD.

Subjects

MeSH terms (MEDLINE)

PomegranateAlzheimer DiseaseMiceAnimalsAntioxidantsNeuroinflammatory DiseasesPolyphenolsInflammationMemory DisordersOxidation-ReductionMicrogliaHydrolyzable Tannins

Author keywords

NLRP3aginglearning and memoryneuroinflammationpunicalagin

Substances

AntioxidantsPolyphenolspunicalaginHydrolyzable Tannins

Authors and institutions

  • Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.
  • Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, People's Republic of China.
  • Department of Endocrinology, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.

ORCID profiles: Peng Chen, Benhong Zhou

Funding

  • Hubei Provincial Natural Science Foundation of China

Cite

APA

Chen, P., Chen, F., Lei, J., & Zhou, B. (2023). Pomegranate polyphenol punicalagin improves learning memory deficits, redox homeostasis, and neuroinflammation in aging mice. Phytotherapy Research, 37(9), 3655-3674. https://doi.org/10.1002/ptr.7848

Vancouver

Chen P, Chen F, Lei J, Zhou B. Pomegranate polyphenol punicalagin improves learning memory deficits, redox homeostasis, and neuroinflammation in aging mice. Phytotherapy Research. 2023;37(9):3655-3674. doi:10.1002/ptr.7848

BibTeX
@article{Chen2023,
  author = {Chen, Peng and Chen, Fuchao and Lei, Jiexin and Zhou, Benhong},
  title = {Pomegranate polyphenol punicalagin improves learning memory deficits, redox homeostasis, and neuroinflammation in aging mice},
  journal = {Phytotherapy Research},
  year = {2023},
  volume = {37},
  number = {9},
  pages = {3655--3674},
  doi = {10.1002/ptr.7848}
}
Start for free →